- Home
- XBIO vs IMTE Comparison
XBIO vs IMTE Comparison
Compare XBIO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- IMTE
- Stock Information
- Founded
- XBIO N/A
- IMTE 2008
- Country
- XBIO United States
- IMTE Malaysia
- Employees
- XBIO N/A
- IMTE N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- XBIO Health Care
- IMTE Consumer Staples
- Exchange
- XBIO Nasdaq
- IMTE Nasdaq
- Market Cap
- XBIO 4.2M
- IMTE 4.1M
- IPO Year
- XBIO N/A
- IMTE N/A
- Fundamental
- Price
- XBIO $2.91
- IMTE $1.18
- Analyst Decision
- XBIO Hold
- IMTE
- Analyst Count
- XBIO 1
- IMTE 0
- Target Price
- XBIO N/A
- IMTE N/A
- AVG Volume (30 Days)
- XBIO 9.5K
- IMTE 12.7K
- Earning Date
- XBIO 05-13-2025
- IMTE 05-27-2025
- Dividend Yield
- XBIO N/A
- IMTE N/A
- EPS Growth
- XBIO N/A
- IMTE N/A
- EPS
- XBIO N/A
- IMTE N/A
- Revenue
- XBIO $2,582,728.00
- IMTE $123,337.00
- Revenue This Year
- XBIO $14.23
- IMTE N/A
- Revenue Next Year
- XBIO N/A
- IMTE N/A
- P/E Ratio
- XBIO N/A
- IMTE N/A
- Revenue Growth
- XBIO 5.63
- IMTE 4.75
- 52 Week Low
- XBIO $2.20
- IMTE $0.51
- 52 Week High
- XBIO $5.20
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- XBIO 49.56
- IMTE 43.21
- Support Level
- XBIO $2.78
- IMTE $1.16
- Resistance Level
- XBIO $3.22
- IMTE $1.26
- Average True Range (ATR)
- XBIO 0.24
- IMTE 0.07
- MACD
- XBIO 0.03
- IMTE 0.01
- Stochastic Oscillator
- XBIO 34.16
- IMTE 47.06
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.